HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Easty Selected Research

LCRF-0004

1/2019When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David Easty Research Topics

Disease

2Neoplasms (Cancer)
01/2019 - 09/2006
1Melanoma (Melanoma, Malignant)
09/2006

Drug/Important Bio-Agent (IBA)

1N- (4- (2- amino- 3- chloropyridin- 4- yloxy)- 3- fluorophenyl)- 4- ethoxy- 1- (4- fluorophenyl)- 2- oxo- 1,2- dihydropyridine- 3- carboxamideIBA
01/2019
1LCRF-0004IBA
01/2019
16-pyruvoyltetrahydropterin synthase (PTPS)IBA
09/2006
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
09/2006
1Protein Tyrosine PhosphatasesIBA
09/2006

Therapy/Procedure

1Therapeutics
09/2006